CRYOPRESERVED CELLS ARE NATURAL KILLERS PRELOADED WITH ANTIBODY CONSTRUCTION Russian patent published in 2024 - IPC C12N5/783 C07K16/28 C07K16/30 A01N1/02 A61K35/17 A61K39/395 A61P35/00 

Abstract RU 2819927 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to a human isolated natural killer cell (NK cell) in a cryopreserved state. Said cell is intended for producing an NK cell capable of exhibiting a cytotoxic effect on a target cell, and is pre-loaded before freezing with an antibody construct comprising a first binding domain binding to an NK cell receptor antigen on the cell surface of an immunological effector cell, and a second binding domain binding to the cell surface antigen on the cell surface of the target cell. Said first and second binding domains contain three light chain CDRs and three heavy chain CDRs. Present invention also relates to methods of producing NK cells, a pharmaceutical composition and a method of treating a tumor disease.

EFFECT: present invention enables to maintain the antibody structure in a state bound to the cell surface even during and after the NK cell is in a cryopreserved state.

29 cl, 9 dwg, 6 tbl, 4 ex

Similar patents RU2819927C2

Title Year Author Number
ANTI-LILRB1 ANTIBODY AND ITS USE 2020
  • Choi, Yoon Aa
  • Kim, Jung A
  • Jung, Saem
  • Lee, Ji Hyun
  • Na, Kyubong
  • Kim, Yeonchul
  • Kim, Han Byul
RU2801535C1
ANTI-LILRB1 ANTIBODY AND USES THEREOF 2021
  • Choi, Yoon Aa
  • Kim, Han Byul
  • Kang, Shinyoung
  • Kim, Jung A
  • Kim, Heehang
  • Kim, Minsoon
  • Cho, Junhaeng
RU2813373C1
RECOVERED ANTIBODY (VERSIONS), A METHOD FOR PRODUCING THE ANTIBODY, AN ISOLATED NUCLEIC ACID, AN EXPRESSION CASSETTE (VERSIONS), A PLASMID (VERSIONS), A HOST CELL, A PHARMACEUTICAL PREPARATION, A KIT, A METHOD OF TREATING A PATIENT, AT RISK OF OR SUFFERING FROM ESCHERICHIA COLI INFECTION, AND A DIAGNOSTIC TECHNIQUE FOR DETERMINING ESCHERICHIA COLI INFECTIONS 2014
  • Vaskes Maksimiliano
  • Gvchalya Luis
  • Nad Gabor
  • Nad Ester
  • Sijyarto Valeriya
RU2724530C2
ANTI-TRBC1 ANTIGEN-BINDING DOMAIN 2018
  • Kordoba, Shon
  • Tomas, Sajmon
  • Onuokha, Simobi
  • Dzha, Ram
  • Lim, Ven Chin
RU2791327C2
ANTIGEN-BINDING PROTEINS AGAINST TIGIT AND THEIR APPLICATION METHODS 2018
  • Nielson, Nels, P.
  • Hicklin, Daniel
  • Seidel-Dugan, Cynthia
  • Winston, William
  • Brodkin, Heather
  • Salmeron-Garcia, Jose-Andres
  • Nirschl, Christopher, James
  • Steiner, Philipp
RU2776714C2
AMATOXIN ANTIBODY-DRUG CONJUGATES AND USE THEREOF 2020
  • Makdonakh, Sharlott Fenton
  • Panvar, Radzhiv
  • Khekhler, Torsten
  • Kulke, Mikhael
  • Sarma, Ganapati N.
  • Pal, Andreas
  • Myuller, Kristof
  • Simon, Verner
  • Lutts, Kristian
  • Gallo, Francheska
RU2826004C2
TUMOR-TARGETING AGONIST CD28 ANTIGEN-BINDING MOLECULES 2019
  • George Guy
  • Hofer Thomas
  • Hosse Ralf
  • Klein Christian
  • Moessner Ekkehard
  • Sam Johannes
  • Umana Pablo
  • Thom Jenny Tosca
  • Gasser Stephan
  • Vallier Jean-Baptiste Pierre
  • Fauti Tanja
RU2837821C1
ANTI-IL31 ANTIBODIES FOR USE IN VETERINARY SCIENCE 2020
  • Li, Shyr Jiann
  • Nguyen, Lam
  • Zhan, Hangjun
RU2835543C1
IL4 RECEPTOR ANTIBODIES FOR USE IN VETERINARY SCIENCE 2019
  • Li, Shyr Jiann
  • Nguyen, Lam
  • Chin, Richard
  • Zhan, Hangjun
RU2837141C2
ANTI-SIGLEC-9 ANTIBODY MOLECULES 2020
  • Laeubli, Heinz
  • Schmitt, Simone
  • Esslinger, Christoph
RU2833330C1

RU 2 819 927 C2

Authors

Rojsh, Uve

Kokh, Joakhim

Treder, Martin

Dulat, Kholger J.

Dates

2024-05-28Published

2019-08-26Filed